Abstract
AbstractPhage therapy has been a valuable asset since the 1920s to deal with pathogenic bacterial infections, and has been practised ever since, especially in the former Soviet Union and in eastern Europe. The western world remained sceptical and resorted to the widespread use of antibiotics as soon as they became available. Now that antibiotic resistance among pathogenic bacteria has spread alarmingly and no really new antibiotic compounds are in the pipeline, renewed attention should be directed to the use of phages as antimicrobials in medicine as well as in the health and the agro‐food sector. The history of early phage use, its successes and problems and the current developments in phage research, production and applications in phage control and therapy are critically reviewed in this context. © 2013 Society of Chemical Industry
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Chemical Technology & Biotechnology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
